Genmab AS Tangible Net Worth Ratio
Genmab AS tangible net worth ratio. Genmab AS (GMAB) has a Tangible Net Worth Ratio of -56.0% as of December 2025. This metric is calculated by deducting intangible assets ($9.10 Billion) from net assets ($5.83 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Genmab AS net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Genmab AS (2002–2025)
Tangible net worth ratio of Genmab AS from 2002 to 2025. This chart shows how Genmab AS's Tangible Net Worth Ratio has changed across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at -56.0%, reflecting net assets of $5.83 Billion with intangible assets of $9.10 Billion USD. Check GMAB PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Genmab AS Tangible Net Worth Ratio by Year (2002–2025)
Genmab AS tangible net worth ratio by year from 2002 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Genmab AS from 2002 to 2025, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Genmab AS (GMAB) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -56.0% | $5.83 Billion | $9.10 Billion | $12.84 Billion | ▼ -122.4 pp |
| 2024 | 66.4% | $36.70 Billion | $12.34 Billion | $45.81 Billion | ▼ -33.3 pp |
| 2023 | 99.7% | $31.61 Billion | $101.00 Million | $35.29 Billion | ▲ +0.2 pp |
| 2022 | 99.5% | $27.28 Billion | $146.00 Million | $30.12 Billion | ▲ +0.6 pp |
| 2021 | 98.9% | $22.20 Billion | $254.00 Million | $24.63 Billion | ▲ +0.6 pp |
| 2020 | 98.2% | $19.12 Billion | $338.00 Million | $21.14 Billion | ▲ +1.6 pp |
| 2019 | 96.7% | $14.05 Billion | $470.00 Million | $15.14 Billion | ▲ +2.5 pp |
| 2018 | 94.1% | $8.01 Billion | $470.36 Million | $8.46 Billion | ▼ -3.9 pp |
| 2017 | 98.0% | $6.27 Billion | $124.39 Million | $6.60 Billion | ▲ +1.8 pp |
| 2016 | 96.2% | $4.83 Billion | $181.90 Million | $5.24 Billion | ▲ +1.8 pp |
| 2015 | 94.5% | $3.49 Billion | $192.64 Million | $3.90 Billion | ▼ -2.4 pp |
| 2014 | 96.9% | $2.03 Billion | $62.53 Million | $2.87 Billion | ▼ -2.7 pp |
| 2013 | 99.6% | $659.52 Million | $2.54 Million | $1.73 Billion | ▼ -0.4 pp |
| 2012 | 100.0% | $383.19 Million | $0.00 | $1.69 Billion | ▲ +0.0 pp |
| 2011 | 100.0% | $486.42 Million | $0.00 | $1.56 Billion | ▲ +0.0 pp |
| 2010 | 100.0% | $1.08 Billion | $0.00 | $2.48 Billion | ▲ +0.0 pp |
| 2009 | 100.0% | $1.30 Billion | $0.00 | $2.22 Billion | ▲ +0.0 pp |
| 2008 | 100.0% | $2.19 Billion | $0.00 | $3.26 Billion | ▲ +0.0 pp |
| 2007 | 100.0% | $2.88 Billion | $0.00 | $3.96 Billion | ▲ +0.0 pp |
| 2006 | 100.0% | $1.61 Billion | $0.00 | $1.80 Billion | ▲ +0.0 pp |
| 2005 | 100.0% | $1.12 Billion | $0.00 | $1.37 Billion | ▲ +0.9 pp |
| 2004 | 99.1% | $1.18 Billion | $10.72 Million | $1.27 Billion | ▲ +2.2 pp |
| 2003 | 96.9% | $1.09 Billion | $33.77 Million | $1.18 Billion | ▲ +1.5 pp |
| 2002 | 95.4% | $1.40 Billion | $64.60 Million | $1.58 Billion | — |